PTK2 and breast cancer: Downregulation of SIRT3 in breast cancer cells supports increased mROS signaling that increases Src-dependent phosphorylation of FAK (Tyr576/577) and p130Cas (Y410) at the leading-edge membrane (Lee et al., 2018).